Aisling Capital Management LP ELEV Holdings History
Aisling Capital Management LP's Elevation Oncology Inc Holding Summary
As of 2025-03-31, Aisling Capital Management LP held 2.83 Mil shares of Elevation Oncology Inc(ELEV), totaling $734,530.00. This investment constitutes 0.25% of their stock portfolio, and Aisling Capital Management LP now holds 4.79% of the outstanding Elevation Oncology Inc(ELEV) stock.
The initial trade took place in 2021Q3. And since then Aisling Capital Management LP has made 1 purchases of ELEV, at an average price of $10.88, for a total of 2.83 Mil shares. Based on historical transaction data and ELEV's current price of $0.37, Aisling Capital Management LP's estimated gain on his ELEV holdings is $-29.81 Mil, reflecting a -96.65% gain to date.
Aisling Capital Management LP ELEV ($0.37) Holding Chart
Aisling Capital Management LP ELEV ($0.37) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
